Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study
Article Details
Authors (15)
Stephen O. Brennan
Departments of Neurology (S.O.B., P.J.K.), Mater Misericordiae University Hospital, Dublin, Ireland.
Peter J. Kelly
Mater Misericordiae University Hospital, Dublin, Ireland (P.J.K.).
Sarah Gorey
Geriatric Medicine Fellowship Program, Harvard Medical School, Boston
Pádraig Synnott
Health Research Board, Stroke Clinical Trials Network Ireland, Dublin, Ireland (P.J.K., S.G., P.S., J.J.M.).
Dipender Gill
Martin Dichgans
Marios K. Georgakis
Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Germany (M.D., M.K.G.).
Marie-Joe Dib
Cardiovascular Division, Perelman School for Advanced Medicine, University of Pennsylvania, Philadelphia (M.-J.D.).
Eloi Gagnon
Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Canada (E.G.).
Niall Mahon
Stroke Service, and Department of Cardiology (N.M., G.J.B.), Mater Misericordiae University Hospital, Dublin, Ireland.
Gavin J. Blake
Stroke Service, and Department of Cardiology (N.M., G.J.B.), Mater Misericordiae University Hospital, Dublin, Ireland.
Christina Jern
Hugh S. Markus
William Whiteley
John J. McCabe
Geriatric Medicine (J.J.M.), Mater Misericordiae University Hospital, Dublin, Ireland.